Literature DB >> 6485876

Charcoal hemoperfusion for treatment of serious carbamazepine poisoning.

C Nilsson, G Sterner, J Idvall.   

Abstract

A case of severe carbamazepine intoxication (total dose 80 g) is reported. Because of deep coma and cardiovascular symptoms, intensive care and hemoperfusion were employed. The carbamazepine hemoperfusion clearance rate was 80-90 ml/min, but due to a probable ongoing absorption from the gut the effect of hemoperfusion was limited. Long hemoperfusion periods are recommended due to the pharmacokinetic pattern of carbamazepine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6485876     DOI: 10.1111/j.0954-6820.1984.tb03783.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  6 in total

1.  Successful treatment of severe carbamazepine toxicity with 5% albumin-enhanced continuous venovenous hemodialysis.

Authors:  Rajeev Narayan; Meagan Rizzo; Michael Cole
Journal:  J Artif Organs       Date:  2014-01-22       Impact factor: 1.731

Review 2.  Clinical toxicology.

Authors:  J A Vale
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

3.  Signs and symptoms of carbamazepine overdose.

Authors:  S Schmidt; M Schmitz-Buhl
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

Review 4.  Carbamazepine toxicity and poisoning. Incidence, clinical features and management.

Authors:  L Durelli; U Massazza; R Cavallo
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 5.  Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Marc Ghannoum; Christopher Yates; Tais F Galvao; Kevin M Sowinski; Thi Hai Vân Vo; Andrew Coogan; Sophie Gosselin; Valery Lavergne; Thomas D Nolin; Robert S Hoffman
Journal:  Clin Toxicol (Phila)       Date:  2014-10-30       Impact factor: 4.467

6.  Effectivity of one session charcoal hemoperfusion treatment in severe carbamazepine poisoning.

Authors:  Yasemin Isik; Lokman Soyoral; Sevdegul Karadas; Habib Emre; Muhammed Bilal Cegin; Ugur Goktas
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.